The document discusses a telemedicine and wellness platform that provides psychosocial counseling, vital sign monitoring, and stress level reports using a PPG sensor with over 95% accuracy compared to FDA approved devices. It has signed contracts with counseling and telemedicine companies in Korea, US, and EU and received KFDA approval for its medical algorithm. The financial projections estimate reaching 1 million users by 2021, generating $3 million in annual revenue at a 5% monthly retention rate.